MOH vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

MOH

44.9
AI Score
VS
MOH Wins

CLOV

36.9
AI Score

Investment Advisor Scores

MOH

45score
Recommendation
HOLD

CLOV

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric MOH CLOV Winner
Forward P/E 20.79 37.7358 MOH
PEG Ratio 1.106 0 Tie
Revenue Growth -3.5% 53.1% CLOV
Earnings Growth -51.5% 0.0% CLOV
Tradestie Score 44.9/100 36.9/100 MOH
Profit Margin -0.1% 0.4% CLOV
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY MOH

Relative Price Performance (Last 90 Days)

MOH 1M: -1.4% · 3M: +3.2% CLOV 1M: +6.0% · 3M: +16.2%

Current Technical Phase

MOH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.6% over 20 days), RSI 52

RSI (14): 52.4 · Price: $209.49

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.3% over 20 days), RSI 59

RSI (14): 58.5 · Price: $4.96

Fundamentals Snapshot

Metric MOH CLOV
Market Cap — —
Forward P/E 22.0 27.6
Trailing P/E — 488.0
Revenue (TTM) — —
Revenue Growth 0.0% 0.5%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.0%
EPS -0.68 0.01
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MOH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.